Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meningococcal ACYW135 Conjugate Vaccine in Healthy Infants
NCT05252715Phase 3Active, not recruiting
- Sponsor
- Zhifei Green Bamboo
- Start
- Dec 2021
- Primary completion
- Aug 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of meningococcal ACYW135 polysaccharide conjugate vaccine in meningococcal meningitis (2 arms), sponsored by Zhifei Green Bamboo. Primary endpoint: Immunogenicity positive conversion rate. Started Dec 2021; status: active, not recruiting.
02
Drugs
meningococcal ACYW135 polysaccharide conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT05252715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05252715.